Brief: Lineage Cell Therapeutics Awarded Grant From Israel Innovation Authority For Development Of A Bio-Retinal Patch For Treatment Of Retinal Diseases In Partnership With Precise Bio
08/09/2020 13:48
Sept 8 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS AWARDED GRANT FROM ISRAEL
INNOVATION
AUTHORITY FOR DEVELOPMENT OF A BIO-RETINAL PATCH FOR TREATMENT
OF RETINAL DISEASES IN PARTNERSHIP WITH PRECISE BIO
Source text for Eikon: ID:nBw77SzkTa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million